2. The drug behind Europe's most valuable com...

Is it fair that only some businesses have access to Anthropic’s super-powerful Mythos AI, given its ability to pierce cyber defences? Will OpenAI go bust? Will Demis Hassabis win the AI wars? Robert Peston talks to Sebastian Mallaby about his biography of British AI genius Demis ...  Show more

Why are one million young people not in education, employment or training? Is the benefits system part of the problem? Are schools out of date? What’s the alternative? Steph talks to former health minister Alan Milburn – who is leading a review into NEETS -about the systemic heal ...  Show more

It’s become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sa ...  Show more

Episode 146: Neal and Toby list off all the exciting tidbits from Apple's big product event, including the iPhone 15 reveal. Next, how a covid-era government program is affecting poverty rates in America. Plus, quick relief from a cold may be gone as FDA declares a key ingredient ...  Show more

In the first of two episodes this week, we're taking a deep dive into the pharmaceutical industry.

How much does the medication you take actually cost? What if a company came along and bought the rights to a particular drug and started charging double, triple, or even 1 ...

On this week's episode of Networth and Chill, I'm joined by author and CEO of Rhoshan Pharmaceuticals, Hitha Palepu to talk drug prices and the pharmaceutical industry. Drug prices are a hot topic these days, and it seems like the cost of life saving medications like insulin and ...  Show more